Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Net Cash Flow: 2018-2024

Historic Net Cash Flow for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$6.5 million.

  • Eton Pharmaceuticals' Net Cash Flow rose 357.42% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 1032.01%. This contributed to the annual value of -$6.5 million for FY2024, which is 226.93% down from last year.
  • As of FY2024, Eton Pharmaceuticals' Net Cash Flow stood at -$6.5 million, which was down 226.93% from $5.1 million recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Net Cash Flow high stood at $9.2 million for FY2020, and its period low was -$6.9 million during FY2021.
  • For the 3-year period, Eton Pharmaceuticals' Net Cash Flow averaged around $176,667, with its median value being $1.9 million (2022).
  • In the last 5 years, Eton Pharmaceuticals' Net Cash Flow skyrocketed by 167.67% in 2023 and then crashed by 226.93% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Net Cash Flow stood at $9.2 million in 2020, then crashed by 174.65% to -$6.9 million in 2021, then spiked by 127.57% to $1.9 million in 2022, then skyrocketed by 167.67% to $5.1 million in 2023, then plummeted by 226.93% to -$6.5 million in 2024.